RhoV Promotes Proliferation, Migration, and MAPK Activation in Pancreatic Ductal Adenocarcinoma
Shang Wu, Jia Feng, Ting Wang, Kyler Hwa, Selina Kao, Ying Xiao, Dongfang Yang, Xinjian Li, Zebang Li, Ryan Liu, Yancheng Liu, Yikai Lu, Xiaoxu Zhou, Yifei Liu, Chiung-Kuei Huang, Shuai Lü
This study identifies RhoV as an oncogenic driver in PDAC, showing it promotes proliferation, migration, and MAPK activation, with potential as a therapeutic target.
American Journal Of Pathology · Feb 26, 2026Peer-reviewedCancer Biology